Page last updated: 2024-12-10

ornoprostil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ornoprostil: RN given refers to (11alpha,13E,15R,17S)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5282205
CHEMBL ID2107020
CHEBI ID31937
SCHEMBL ID122454
MeSH IDM0131381

Synonyms (45)

Synonym
ronoprost
ronok
ornoprostil
ou-1308
alloca
prost-13-en-1-oic acid, 11,15-dihydroxy-17,20-dimethyl-6,9-dioxo-, methyl ester, (11-alpha,13e)-
ornoprostilum [latin]
methyl (-)-(1r,2r,3r)-3-hydroxy-2-((e)-(3s,5s)-3-hydroxy-5-methyl-1-nonenyl)-epsi,5-dioxocyclopentaneheptanoate
ornoprostil [inn:jan]
ornoprostilo [spanish]
brn 4015952
methyl (-)-(1r,2r,3r)-3-hydroxy-2-((e)-(3s,5s)-3-hydroxy-5-methyl-1-nonenyl)-epsilon,5-dioxocyclopentaneheptanoate
ou 1308
70667-26-4
ornoprostil (jan/inn)
ronok (tn)
D01869
methyl 7-[(1r,2r,3r)-2-[(e,3s,5s)-5-methyl-3-oxidanyl-non-1-enyl]-3-oxidanyl-5-oxidanylidene-cyclopentyl]-6-oxidanylidene-heptanoate
7-[(1r,2r,3r)-3-hydroxy-2-[(e,3s,5s)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]-6-oxoheptanoic acid methyl ester
A836955
methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(e,3s,5s)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]-6-oxoheptanoate
CHEMBL2107020
i4lk9lh4dj ,
ornoprostilo
unii-i4lk9lh4dj
ornoprostilum
ornoprostil [jan]
ornoprostil [who-dd]
ornoprostil [mart.]
ornoprostil [mi]
ornoprostil [inn]
methyl (-)-(1r,2r,3r)-3-hydroxy-2-((e)-(3s,5s)-3-hydroxy-5-methyl-1-nonenyl)-.epsilon.,5-dioxocyclopentaneheptanoate
SCHEMBL122454
methyl 7-{(1r,2r,3r)-3-hydroxy-2-[(1e,3s,5s)-3-hydroxy-5-methyl-1-nonenyl]-5-oxocyclopentyl}-6-oxoheptanoate
BBRBUTFBTUFFBU-LHACABTQSA-N
cyclopentaneheptanoicacid,3-hydroxy-2-[(1e,3s,5s)-3-hydroxy-5-methyl-1-nonen-1-yl]-e,5-dioxo-,methyl ester,(1r,2r,3r)-
CHEBI:31937
methyl 7-((1r,2r,3r)-3-hydroxy-2-((3s,5s,e)-3-hydroxy-5-methylnon-1-enyl)-5-oxocyclopentyl)-6-oxoheptanoate
methyl 7-((1r,2r,3r)-3-hydroxy-2-((3s,5s,e)-3-hydroxy-5-methylnon-1-en-1-yl)-5-oxocyclopentyl)-6-oxoheptanoate
Q27280441
EX-A5558
DTXSID901021616
CS-0021514
HY-101477
AKOS040744671
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (35.71)18.7374
1990's6 (42.86)18.2507
2000's2 (14.29)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.50 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews2 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (78.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]